Focus on Oral Care and Sale of the Pharmaceuticals Business
01. Juin 2021
- Wild & Co. AG will focus exclusively on one of its core competencies: its domestically and internationally successful oral care business under the leading umbrella brands Tebodont®, Emoform®, Emofluor®, Depurdent® and Emofresh®.
- Wild & Co. AG has therefore sold its pharma business, i.e. inter alia its leading vitamin D product portfolio with the brands Vi-De 3 und Vitamin D3 Wild Öl, and the well-established brands Deaftol, Oxyplastin, Contra-Schmerz, Tonoglutal and Salvia Wild and the respective marketing authorizations, to Verfora AG, an affiliate of Galenica Group (SIX Swiss Exchange: GALE), at the end of May 2021.
- By focusing on its already strongly positioned oral care business for which all core products are manufactured at its own and modern factory in Muttenz, Switzerland, Dr. Wild & Co. AG will be able to leverage the growth potential in the oral care sector both in Switzerland and abroad.
- For more information, please find attached today's press release.